Is idiopathic intracranial hypertension without papilledema a risk factor for migraine progression?

scientific article published on 25 February 2010

Is idiopathic intracranial hypertension without papilledema a risk factor for migraine progression? is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1007/S10072-010-0229-1
P698PubMed publication ID20182895

P2093author name stringRoberto De Simone
Vincenzo Bonavita
Leonilda Bilo
Angelo Ranieri
Chiara Fiorillo
P2860cites workIdiopathic intracranial hypertension (Pseudotumor cerebri)Q22252601
Factors associated with the onset and remission of chronic daily headache in a population-based studyQ28212746
The International Classification of Headache Disorders: 2nd editionQ29547231
Diagnostic criteria for idiopathic intracranial hypertensionQ34161245
Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis.Q34196440
Utility of CSF pressure monitoring to identify idiopathic intracranial hypertension without papilledema in patients with chronic daily headacheQ34322063
Classification of daily and near-daily headaches: proposed revisions to the IHS criteriaQ34337439
New appendix criteria open for a broader concept of chronic migraineQ34523930
Probable medication-overuse headache: the effect of a 2-month drug-free periodQ34527544
Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label studyQ34699512
The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF).Q36261290
Concepts and mechanisms of migraine chronificationQ37053916
Towards a definition of comorbidity in the light of clinical complexityQ37188662
Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramateQ37237787
Clinical course in migraine: conceptualizing migraine transformationQ37263760
Clinical review: the surgical treatment of idiopathic pseudotumour cerebri (idiopathic intracranial hypertension).Q37336076
What predicts the change from episodic to chronic migraine?Q37452668
Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuseQ37593181
A new drug for an old condition?Q44249113
Does chronic daily headache arise de novo in association with regular use of analgesics?Q44326422
Topiramate-responsive headache due to idiopathic intracranial hypertension in Behçet syndromeQ44898797
Transformed or evolutive migraineQ44957670
Prevalence of frequent headache in a population sampleQ46159664
Transverse sinus stenoses persist after normalization of the CSF pressure in IIH.Q46745942
The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri)Q47274308
Kaplan Award 1998. Epidemiology of chronic daily headache in the general populationQ48345830
Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structuresQ48443633
Sleep disorders: a risk factor for pseudotumor cerebri?Q48687580
Pseudotumor Cerebri Syndrome Without PapilledemaQ48752438
Transformed migraineQ48871775
Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.Q50617460
Reversibility of venous sinus obstruction in idiopathic intracranial hypertension.Q51029167
Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.Q51756573
Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness.Q51787120
Chronic migraine is an earlier stage of transformed migraine in adults.Q51924006
Migraine aggravation caused by cephalic venous congestion.Q52953264
Idiopathic intracranial hypertension with and without papilloedema in a consecutive series of patients with chronic migraine.Q53217837
Application of ICHD-II and revised diagnostic criteria to patients with chronic daily headache.Q53239728
The International Classification of Headache Disorders revised criteria for chronic migraine—field testing in a headache specialty clinic.Q53242572
Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life.Q53345398
Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies.Q54154464
Idiopathic Intracranial Hypertension Without HeadacheQ57991896
Idiopathic Intracranial Hypertension Without Papilloedema in Headache SufferersQ62782106
Bilateral transverse sinus stenosis and idiopathic intracranial hypertension without papilledema in chronic tension-type headacheQ62782144
Bilateral transverse sinus stenosis predicts IIH without papilledema in patients with migraineQ62782232
Idiopathic intracranial hypertension without papilledemaQ70134413
Coexistence of migraine and idiopathic intracranial hypertension without papilledemaQ71074206
Classification of daily and near-daily headaches: field trial of revised IHS criteriaQ71656653
Topiramate as an inhibitor of carbonic anhydrase isoenzymesQ73683760
The economic impact of migraine: an analysis of direct and indirect costsQ74587632
Idiopathic intracranial hypertension without papilledema: a case-control study in a headache centerQ74801011
Manometry combined with cervical puncture in idiopathic intracranial hypertensionQ77461992
Changes in the appearance of venous sinuses after treatment of disordered intracranial pressureQ80000497
Lateral sinus stenoses in idiopathic intracranial hypertension resolving after CSF diversionQ80124232
Chronic daily headache: correlation between the 2004 and the 1988 International Headache Society diagnostic criteriaQ80226503
A model for idiopathic intracranial hypertension and associated pathological ICP wave-formsQ80687043
Cephalic venous congestion aggravates only migraine-type headachesQ80856952
Application of revised criteria for chronic migraine and medication overuse headache in a tertiary Headache CentreQ81436125
Sudden re-opening of collapsed transverse sinuses and longstanding clinical remission after a single lumbar puncture in a case of idiopathic intracranial hypertension. Pathogenetic implicationsQ81436855
P433issue4
P921main subjectarterial hypertensionQ41861
migraineQ133823
papilledemaQ953049
risk factorQ1475848
intracranial hypertensionQ18558125
P304page(s)411-415
P577publication date2010-02-25
P1433published inNeurological SciencesQ15763262
P1476titleIs idiopathic intracranial hypertension without papilledema a risk factor for migraine progression?
P478volume31